Finance News – U.S.

All U.S. UK Canada Australia India Global Global (Crypto)

What is your interest today?

Tariffs Investors Ceo Stock Earnings Shares Stocks China Eqs Nasdaq Investment Markets Cet Trade Wall Street Nvidia Revenue Tesla Stock Market Class Action Securities Economy Bitcoin Sales Inflation Us Trade War Prices Company Apple Sp 500 Crypto Federal Reserve Warren Buffett Guidance Companies Interest Rates Amazon Berkshire Hathaway Shareholders Federal Securities Laws Ipo Pvr Walmart Profit Investor Trading Securities Laws Gop Boeing Costs Us Stocks Financial Services Labor Department First Quarter Results Adjusted Earnings Per Share Toy Company Digital City Cdc Alk

Filter by:

Trpv3 Inhibitor × U.S. ×

Business Insider Markets • Jun 03, 2025

Kamari Pharma Announces Closing of $23 Million Financing to Advance its First-In-Class Oral TRPV3 In...

Kamari Pharma secured $23 million in funding led by BRM Group and Pontifax to support the clinical development of its novel oral TRPV3 inhibitor targeting rare genetic skin conditi...

Read Full Article →